Intelligence Platform
Patents
Browse 225 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6630144
Monoclonal antibodies to Ebola glycoprotein
expired patentUS 6620412
Prophylactic and therapeutic monoclonal antibodies
expired patentUS 6613556
Adaptation of virus to vertebrate cells
expired patentUS 6573244
Previns as specific inhibitors and therapeutic agents for Botulinum toxin B and Tetanus ne
expired patentUS 6562376
DNA vaccines against poxviruses
expired patentUS 6541230
Detoxification with sponges or foams containing plurality of enzymes and encapsulated indi
expired patentUS 6537557
Attenuated dengue-4 virus vaccine
expired patentUS 6528097
Sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
expired patentUS 6528065
Attenuated dengue-3 virus vaccine
expired patentUS 6517842
Marburg virus vaccines
expired patentUS 6514501
Recombinant vaccine against dengue virus
expired patentUS 6511667
Attenuated dengue-2 virus vaccine
expired patentUS 6495143
Botulinum neurotoxin vaccine
expired patentUS 6476201
Methods for the production of non-covalently complexed and multivalent proteosome sub-unit
expired patentUS 6472438
Active topical skin protectants containing S-330
expired patentUS 6472437
Active topical skin protectants
expired patentUS 6469049
Method of treating, preventing or inhibiting central nervous system injuries and diseases
expired patentUS 6451309
Prophylactic and therapeutic monoclonal antibodies
expired patentUS 6447796
Sustained release hydrophobic bioactive PLGA microspheres
expired patentUS 6444445
Live vaccine against Brucellosis
expired patentUS 6437005
Active topical skin protectants using polymer coated metal alloys
expired patentUS 6432434
Treatment of and/or prophylaxis against brain and spinal cord injury
expired patentUS 6433023
Compositions having anti-leishmanial activity
expired patentUS 6420434
Active topical skin protectants using polyoxometallates
expired